Bruker (NASDAQ:BRKR) Sets New 12-Month Low - Time to Sell?

Bruker Co. (NASDAQ:BRKR - Get Free Report)'s stock price hit a new 52-week low on Wednesday . The company traded as low as $45.29 and last traded at $46.42, with a volume of 1844984 shares traded. The stock had previously closed at $46.74.

Analyst Ratings Changes

BRKR has been the subject of several research reports. Stifel Nicolaus reduced their price target on shares of Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research report on Friday, February 14th. Guggenheim reissued a "buy" rating on shares of Bruker in a research report on Monday, February 24th. The Goldman Sachs Group raised shares of Bruker from a "sell" rating to a "neutral" rating and set a $60.00 price target on the stock in a research report on Thursday, December 5th. UBS Group initiated coverage on Bruker in a report on Tuesday, December 10th. They set a "neutral" rating and a $66.00 price objective for the company. Finally, Bank of America raised their target price on Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a report on Friday, December 13th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $70.50.

Bruker Stock Up 0.4 %

The company has a market capitalization of $7.34 billion, a P/E ratio of 63.70, a PEG ratio of 2.16 and a beta of 1.16. The stock has a 50 day moving average price of $55.17 and a 200 day moving average price of $59.20. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60.

Remove Ads

Bruker (NASDAQ:BRKR - Get Free Report) last released its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities research analysts forecast that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.41%. Bruker's dividend payout ratio is presently 26.32%.

Institutional Investors Weigh In On Bruker

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Gordian Capital Singapore Pte Ltd bought a new position in Bruker during the fourth quarter worth about $234,000. EDENTREE ASSET MANAGEMENT Ltd grew its stake in Bruker by 11.2% in the 4th quarter. EDENTREE ASSET MANAGEMENT Ltd now owns 158,000 shares of the medical research company's stock valued at $9,262,000 after buying an additional 15,900 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Bruker by 17.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 356,969 shares of the medical research company's stock valued at $20,926,000 after acquiring an additional 52,214 shares during the period. Voloridge Investment Management LLC boosted its holdings in shares of Bruker by 179.6% in the fourth quarter. Voloridge Investment Management LLC now owns 18,906 shares of the medical research company's stock worth $1,108,000 after acquiring an additional 12,145 shares during the period. Finally, Two Sigma Advisers LP grew its position in shares of Bruker by 406.1% in the fourth quarter. Two Sigma Advisers LP now owns 140,700 shares of the medical research company's stock valued at $8,248,000 after purchasing an additional 112,900 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.